United States · FDA National Drug Code directory
Hydromorphone Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0703-0113_540b835a-db66-417c-8507-0c1ed05c95bf
- Product NDC
- 0703-0113
- Form
- INJECTION, SOLUTION
- Composition / generic term
- HYDROMORPHONE HYDROCHLORIDE
- Labeler
- Teva Parenteral Medicines, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20110118
- Source listing expiry
- 20271231
Source-listed ingredients
- HYDROMORPHONE HYDROCHLORIDE — 10 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 VIAL in 1 CARTON (0703-0113-03) / 5 mL in 1 VIAL (0703-0113-01) · 0703-0113-03
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →